Cited by 160Cannabis and Cannabinoid ResearchReceptor Mechanisms and SignalingNeuroscience and Neuropharmacology Research

The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.

Cannabinoid Receptor Activation Differentially Regulates the Various Adenylyl Cyclase Isozymes

Rhee, Man‐Hee, Bayewitch, Michael, Avidor‐Reiss, Tomer, Levy, Rivka, Vogel, Zvi·1998·Journal of Neurochemistry

DOI 10.1046/j.1471-4159.1998.71041525.x

Open this paper in CoChat — free account

Abstract

Two cannabinoid receptors belonging to the superfamily of G protein-coupled membrane receptors have been identified and cloned: the neuronal cannabinoid receptor (CB1) and the peripheral cannabinoid receptor (CB2). They have been shown to couple directly to the G(i/o) subclass of G proteins and to mediate inhibition of adenylyl cyclase upon binding of a cannabinoid agonist. In several cases, however, cannabinoids have been reported to stimulate adenylyl cyclase activity, although the mechanism by which they did so was unclear. With the cloning of nine adenylyl cyclase isozymes with various properties, including different sensitivities to alpha(s), alpha(i/o), and betagamma subunits, it became important to assess the signaling pattern mediated by each cannabinoid receptor via the different adenylyl cyclase isozymes. In this work, we present the results of cotransfection experiments between the two types of cannabinoid receptors and the nine adenylyl cyclase isoforms. We found that independently of the method used to stimulate specific adenylyl cyclase isozymes (e.g., ionomycin, forskolin, constitutively active alpha(s), thyroid-stimulating hormone receptor activation), activation of the cannabinoid receptors CB1 and CB2 inhibited the activity of adenylyl cyclase types I, V, VI, and VIII, whereas types II, IV, and VII were stimulated by cannabinoid receptor activation. The inhibition of adenylyl cyclase type III by cannabinoids was observed only when forskolin was used as stimulant. The activity of adenylyl cyclase type IX was inhibited only marginally by cannabinoids.

Integrity signals

Registry

Crossref · 10.1046/j.1471-4159.1998.71041525.x

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Molecular characterization of a peripheral receptor for cannabinoids
Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092
Structure of a cannabinoid receptor and functional expression of the cloned cDNA
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011
Expression of Central and Peripheral Cannabinoid Receptors in Human Immune Tissues and Leukocyte Subpopulations
Galiègue, S., Mary, S., Marchand, J., Dussossoy, D., Carrière, D., Carayon, P., Bouaboula, M., Shire, D. J., Fur, G. L., & Casellas, P. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.tb20780.x · Cited by 1,776
Receptor-effector coupling by G proteins
Birnbaumer, L., Abramowitz, J., & Brown, A. M. (1990) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/0304-4157(90)90007-y · Cited by 1,118
Complexity and Diversity of Mammalian Adenylyl Cyclases
Sunahara, R. K., Dessauer, C. W., & Gilman, A. G. (1996) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.36.040196.002333 · Cited by 874
Voltage-dependent modulation of N-type calcium channels by G-protein β γsubunits
Ikeda, S. R. (1996) · Nature · doi:10.1038/380255a0 · Cited by 827
Ras-dependent activation of MAP kinase pathway mediated by G-protein βγ subunits
Crespo, P., Xu, N., Simonds, W. F., & Gutkind, J. S. (1994) · Nature · doi:10.1038/369418a0 · Cited by 801
Adenylyl Cyclase Amino Acid Sequence: Possible Channel- or Transporter-Like Structure
Krupinski, J., Coussen, F., Bakalyar, H. A., Tang, W., Feinstein, P. G., Orth, K., Slaughter, C. A., Reed, R. R., & Gilman, A. G. (1989) · Science · doi:10.1126/science.2472670 · Cited by 738
Mammalian Membrane-bound Adenylyl Cyclases
Taussig, R., & Gilman, A. G. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.1.1 · Cited by 719
SR 144528, the First Potent and Selective Antagonist of the CB2 Cannabinoid Receptor
Rinaldi, M. L., Barth, F., Millan, J., Derocq, J., Casellas, P., Congy, C., Oustric, D., Sarran, M., Bouaboula, M., Calandra, B., et al. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37266-0 · Cited by 716

Show all 56 references

Sorted by citations

International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors
Howlett, A. C., Barth, F., Bonner, T. I., Cabral, G., Casellas, P., Devane, W. A., Felder, C. C., Herkenham, M., Mackie, K., Martin, B. R., et al. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.161 · Cited by 2,819
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
Pacher, P., Bátkai, S., & Kunos, G. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.2 · Cited by 2,077
Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System
Zou, S., & Kumar, U. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030833 · Cited by 1,448
Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain
Marsicano, G., & Lutz, B. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00847.x · Cited by 937
Peripheral cannabinoid receptor, CB2, regulates bone mass
Ofek, O., Karsak, M., Leclerc, N., Fogel, M., Frenkel, B., Wright, K. L., Tam, J., Attar-Namdar, M., Kram, V., Shohami, E., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504187103 · Cited by 547
The cannabinoid system and immune modulation
Klein, T., Newton, C. A., Larsen, K. A., Lu, L. D., Perkins, I., Nong, L., & Friedman, H. P. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0303101 · Cited by 533
Cannabinoid Receptor Signaling
Howlett, A. C. (2005) · Springer eBooks · doi:10.1007/3-540-26573-2_2 · Cited by 473
Cannabinoid signalling
Demuth, D. G., & Molleman, A. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.05.055 · Cited by 435
Signal transduction of the CB1 cannabinoid receptor
Turu, G., & Hunyady, L. (2009) · Journal of Molecular Endocrinology · doi:10.1677/jme-08-0190 · Cited by 354
CB1 Cannabinoid Receptors and their Associated Proteins
Howlett, A. C., Blume, L. C., & Dalton, G. D. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710790980023 · Cited by 310
Pharmacology of Medical Cannabis
Amin, M. R., & Ali, D. W. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-21737-2_8 · Cited by 313
Amygdala FAAH and anandamide: mediating protection and recovery from stress
Gunduz-Cinar, O., Hill, M. N., McEwen, B. S., & Holmes, A. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2013.08.008 · Cited by 229
Palmitoylethanolamide inhibits the expression of fatty acid amide hydrolase and enhances the anti-proliferative effect of anandamide in human breast cancer cells
Marzo, V. D., Melck, D. J., Orlando, P., Bisogno, T., Zagoory, O., Bifulco, M., Vogel, Z., & PETROCELLIS, L. D. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3580249 · Cited by 217
Cannabinoid Receptors and Their Role in Neuroprotection
van der Stelt, M., & Marzo, V. D. (2005) · NeuroMolecular Medicine · doi:10.1385/nmm:7:1-2:037 · Cited by 192
Functionally selective cannabinoid receptor signalling: Therapeutic implications and opportunities
Bosier, B., Muccioli, G. G., Hermans, E., & Lambert, D. M. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.02.013 · Cited by 193
CB2 Receptor in Microglia: The Guardian of Self-Control
Komorowska‐Müller, J. A., & Schmöle, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010019 · Cited by 176
Presence of the cannabinoid receptors, CB1 and CB2, in human omental and subcutaneous adipocytes
Roche, R., Hoareau, L., Bès-Houtmann, S., Gonthier, M., Laborde, C., Baron, J.-F., Haffaf, Y., Césari, M., & Festy, F. (2006) · Histochemistry and Cell Biology · doi:10.1007/s00418-005-0127-4 · Cited by 174
Cannabinoid receptor CB2 localisation and agonist-mediated inhibition of capsaicin responses in human sensory neurons
Anand, U., Otto, W. R., Sanchez-Herrera, D., Facer, P., Yiangou, Y., Korchev, Y., Birch, R., Benham, C., Bountra, C., Chessell, I. P., et al. (2008) · Pain · doi:10.1016/j.pain.2008.06.007 · Cited by 166
Molecular Diversity of Cyclic AMP Signalling
Antoni, F. A. (2000) · Frontiers in Neuroendocrinology · doi:10.1006/frne.1999.0193 · Cited by 153
Differential Roles of CB1 and CB2 Cannabinoid Receptors in Mast Cells
Samson, M.-T., Small-Howard, A. L., Shimoda, L. M. N., Koblan‐Huberson, M., Stokes, A. J., & Turner, H. C. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.10.4953 · Cited by 139
Cannabinoid CB1receptor‐interacting proteins: novel targets for central nervous system drug discovery?
Smith, T. H., Sim‐Selley, L. J., & Selley, D. E. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00777.x · Cited by 119
Signaling pathways involved in the development of cannabinoid tolerance
Martin, B. R., Sim‐Selley, L. J., & Selley, D. E. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.04.005 · Cited by 115
Neuropharmacology of the Endocannabinoid Signaling System-Molecular Mechanisms, Biological Actions and Synaptic Plasticity
Basavarajappa, B. S. (2007) · Current Neuropharmacology · doi:10.2174/157015907780866910 · Cited by 115
Cannabinoids and Neuroprotection
Beltramo, M., Grundy, R. I., & Rabuffetti, M. (2001) · Molecular Neurobiology · doi:10.1385/mn:24:1-3:029 · Cited by 109
A Predominant Role for Inhibition of the Adenylate Cyclase/Protein Kinase A Pathway in ERK Activation by Cannabinoid Receptor 1 in N1E-115 Neuroblastoma Cells
Davis, M. I., Ronesi, J. A., & Lovinger, D. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305697200 · Cited by 112
Dual intracellular signaling pathways mediated by the human cannabinoid CB1 receptor
Calandra, B., Portier, M., Kernéis, A., Delpech, M., Carillon, C., Fur, G. L., Ferrara, P., & Shire, D. J. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00349-0 · Cited by 108
Ligand-Binding Architecture of Human CB2 Cannabinoid Receptor: Evidence for Receptor Subtype-Specific Binding Motif and Modeling GPCR Activation
Pei, Y., Mercier, R. W., Anday, J. K., Thakur, G. A., Zvonok, A. M., Hurst, D. P., Reggio, P. H., Janero, D. R., & Makriyannis, A. (2008) · Chemistry & Biology · doi:10.1016/j.chembiol.2008.10.011 · Cited by 102
Cannabinoid Receptor 2 (CB2) Signals via G-alpha-s and Induces IL-6 and IL-10 Cytokine Secretion in Human Primary Leukocytes
Saroz, Y., Kho, D. T., Glass, M., Graham, E. S., & Grimsey, N. L. (2019) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.9b00049 · Cited by 98
CBD Effects on TRPV1 Signaling Pathways in Cultured DRG Neurons
Anand, U., Jones, B. J., Korchev, Y. E., Bloom, S. R., Pacchetti, B., Anand, P., & Sodergren, M. H. (2020) · Journal of Pain Research · doi:10.2147/jpr.s258433 · Cited by 95
Expression and functions of adenylyl cyclases in the CNS
Devasani, K., & Yao, Y. (2022) · Fluids and Barriers of the CNS · doi:10.1186/s12987-022-00322-2 · Cited by 93
Cannabinoid CB 1 receptors transactivate multiple receptor tyrosine kinases and regulate serine/threonine kinases to activate ERK in neuronal cells
Dalton, G. D., & Howlett, A. C. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01455.x · Cited by 89
Pathways and gene networks mediating the regulatory effects of cannabidiol, a nonpsychoactive cannabinoid, in autoimmune T cells
Kozela, E., Juknat, A., Gao, F., Kaushansky, N., Coppola, G., & Vogel, Z. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0603-x · Cited by 84
Efficacy in CB1 receptor‐mediated signal transduction
Howlett, A. C. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705881 · Cited by 79
Pharmacophores for Ligand Recognition and Activation / Inactivation of the Cannabinoid Receptors
Reggio, P. H. (2003) · Current Pharmaceutical Design · doi:10.2174/1381612033454577 · Cited by 78
Anti-inflammatory potential of CB1-mediated cAMP elevation in mast cells
Small-Howard, A. L., Shimoda, L. M. N., Adra, C. N., & Turner, H. C. (2005) · Biochemical Journal · doi:10.1042/bj20041682 · Cited by 77
CB1 cannabinoid receptor-G protein association: a possible mechanism for differential signaling
Mukhopadhyay, S., Shim, J., Assi, A.-A. A., Norford, D. C., & Howlett, A. C. (2002) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(02)00153-6 · Cited by 74
Cannabinoid pharmacology in the cardiovascular system: potential protective mechanisms through lipid signalling
Hiley, C. R., & Ford, W. R. (2004) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1017/s1464793103006201 · Cited by 70
Arachidonylethanolamide Induces Apoptosis of Human Glioma Cells through Vanilloid Receptor-1
Contassot, E., Wilmotte, R., Tenan, M., Belkouch, M., Schnüriger, V., de Tribolet, N., Bourkhardt, K., & Dietrich, P. (2004) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/63.9.956 · Cited by 67
In-Vitro and In-Vivo Action of Cannabinoids
Akinshola, B. E., Chakrabarti, A., & Onaivi, E. S. (1999) · Neurochemical Research · doi:10.1023/a:1020968922151 · Cited by 66
Intracellular Molecular Targets and Signaling Pathways Involved in Antioxidative and Neuroprotective Effects of Cannabinoids in Neurodegenerative Conditions
Tadijan, A., Vlašić, I., Vlainić, J., Đikić, D., Oršolić, N., & Jembrek, M. J. (2022) · Antioxidants · doi:10.3390/antiox11102049 · Cited by 68
Endocannabinod Signal Dysregulation in Autism Spectrum Disorders: A Correlation Link between Inflammatory State and Neuro-Immune Alterations
Brigida, A. L., Schultz, S. T., Cascone, M., Antonucci, N., & Siniscalco, D. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18071425 · Cited by 61
Cannabinoid CB1 receptors colocalize with tyrosine hydroxylase in cultured fetal mesencephalic neurons and their activation increases the levels of this enzyme
Hernández, M., Berrendero, F., Suárez, I., Garcı́a-Gil, L., Cebeira, M., Mackie, K., Ramos, J. A., & Fernández‐Ruíz, J. (2000) · Brain Research · doi:10.1016/s0006-8993(99)02322-7 · Cited by 58
Targeting the cannabinoid system for pain relief?
Chiou, L., Hu, S. S., & Ho, Y. (2013) · Acta anaesthesiologica Taiwanica · doi:10.1016/j.aat.2013.10.004 · Cited by 59
Psychopharmacology of the endocannabinoids: far beyond anandamide
Pamplona, F. A., & Takahashi, R. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881111405357 · Cited by 61
Differential CB1 and CB2 cannabinoid receptor-inotropic response of rat isolated atria: Endogenous signal transduction pathways
Sterin‐Borda, L., Zar, C. F. D., & Borda, E. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.03.027 · Cited by 56
CB 1 cannabinoid receptor-mediated increases in cyclic AMP accumulation are correlated with reduced Gi/o function
Eldeeb, K., Leone‐Kabler, S., & Howlett, A. C. (2016) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp-2015-0096 · Cited by 55
Cannabis use, abuse, and withdrawal: Cannabinergic mechanisms, clinical, and preclinical findings
Kesner, A. J., & Lovinger, D. M. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15369 · Cited by 58
Differential Superactivation of Adenylyl Cyclase Isozymes after Chronic Activation of the CB1 Cannabinoid Receptor
Rhee, M. H., Nevo, I., Avidor‐Reiss, T., Levy, R., & Vogel, Z. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)26475-0 · Cited by 51
Cannabinoid CB1Receptor-Dependent Long-Term Depression in Autaptic Excitatory Neurons
Kellogg, R. T., Mackie, K., & Straiker, A. J. (2009) · Journal of Neurophysiology · doi:10.1152/jn.00266.2009 · Cited by 51
CB1 cannabinoid receptor‐dependent and ‐independent inhibition of depolarization‐induced calcium influx in oligodendrocytes
Mato, S., Alberdi, E. M., Ledent, C. A., Watanabe, M., & Matute, C. (2008) · Glia · doi:10.1002/glia.20757 · Cited by 50
Adenylyl cyclase type-VIII activity is regulated by Gβγ subunits
Steiner, D., Saya, D., Schallmach, E., Simonds, W. F., & Vogel, Z. (2005) · Cellular Signalling · doi:10.1016/j.cellsig.2005.03.014 · Cited by 48
Role of the highly conserved Asp‐Arg‐Tyr motif in signal transduction of the CB2 cannabinoid receptor
Rhee, M. H., Nevo, I., Levy, R., & Vogel, Z. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01094-2 · Cited by 46
The Macamide N-3-Methoxybenzyl-Linoleamide Is a Time-Dependent Fatty Acid Amide Hydrolase (FAAH) Inhibitor
Almukadi, H. S., Wu, H., Böhlke, M., Kelley, C. J., Maher, T. J., & Pino‐Figueroa, A. J. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8499-2 · Cited by 45
Functional Role of Tryptophan Residues in the Fourth Transmembrane Domainof the CB2 Cannabinoid Receptor
Rhee, M. H., Nevo, I., Bayewitch, M. L., Zagoory, O., & Vogel, Z. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0752485.x · Cited by 42
Inhibition of melanocortin-4 receptor dimerization by substitutions in intracellular loop 2
Piechowski, C. L., Rediger, A., Lagemann, C., Mühlhaus, J., Müller, A., Pratzka, J., Tarnow, P., Grüters, A., Krude, H., Kleinau, G., et al. (2013) · Journal of Molecular Endocrinology · doi:10.1530/jme-13-0061 · Cited by 39
Crosstalk between the M1 muscarinic acetylcholine receptor and the endocannabinoid system: A relevance for Alzheimer's disease?
Thompson, K. J., & Tobin, A. B. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109545 · Cited by 39
The endocannabinoid system in the amygdala and modulation of fear
Gunduz‐Cinar, O. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110116 · Cited by 40
Bone Cell-autonomous Contribution of Type 2 Cannabinoid Receptor to Breast Cancer-induced Osteolysis
Sophocleous, A., Marino, S., Logan, J. G., Mollat, P., Ralston, S. H., & Idris, A. I. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.649608 · Cited by 38
An Overview on the Biochemistry of the Cannabinoid System
Gómez‐Ruíz, M., Hernández, M., de Miguel, R., & Ramos, J. A. (2007) · Molecular Neurobiology · doi:10.1007/s12035-007-0015-0 · Cited by 38
Analysis of natural product regulation of opioid receptors in the treatment of human disease
Badal, S. A. M., Turfus, S. C., Rajnarayanan, R. V., Wilson-Clarke, C. F., & Sandiford, S. L. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.10.021 · Cited by 36
Potential Mechanisms Underlying the Deleterious Effects of Synthetic Cannabinoids Found in Spice/K2 Products
Basavarajappa, B. S., & Subbanna, S. (2019) · Brain Sciences · doi:10.3390/brainsci9010014 · Cited by 34
Neuroprotection and Beyond: The Central Role of CB1 and CB2 Receptors in Stroke Recovery
Bietar, B., Tanner, S., & Lehmann, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242316728 · Cited by 32
Diarylimidazolyl oxadiazole and thiadiazole derivatives as cannabinoid CB1 receptor antagonists
Kim, J. Y., Seo, H. J., Lee, S.-H., Jung, M. E., Ahn, K., Kim, J., & Lee, J. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.10.130 · Cited by 31
Endocannabinoid System and Alcohol Abuse Disorders
Basavarajappa, B. S. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-21737-2_6 · Cited by 32
Chapter 5 Is GPR55 an Anandamide Receptor?
Brown, A. J., & Hiley, C. R. (2009) · Vitamins and hormones · doi:10.1016/s0083-6729(09)81005-4 · Cited by 31
Crosstalk between the endocannabinoid and mid-brain dopaminergic systems: Implication in dopamine dysregulation
Kibret, B. G., Canseco-Alba, A., Onaivi, E. S., & Engidawork, E. (2023) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2023.1137957 · Cited by 30
Regulation of Skeletal Remodeling by the Endocannabinoid System
Bab, I. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1402.014 · Cited by 27
Auto-inhibition of adenylyl cyclase 9 (AC9) by an isoform-specific motif in the carboxyl-terminal region
Pálvölgyi, A., Simpson, J., Bodnár, I., Bíró, J., Palkovits, M., Radovits, T., Skehel, P., & Antoni, F. A. (2018) · Cellular Signalling · doi:10.1016/j.cellsig.2018.08.010 · Cited by 28
The Role of the Cannabinoid System in Opioid Analgesia and Tolerance
Özdemir, E. (2020) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557520666200313120835 · Cited by 28
Inhibition of Fatty Acid Amide Hydrolase (FAAH) by Macamides
Alasmari, M. M., Bӧhlke, M., Kelley, C. J., Maher, T. J., & Pino‐Figueroa, A. J. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1115-8 · Cited by 28
Mutagenesis and computer modeling studies of a GPCR conserved residue W5.43(194) in ligand recognition and signal transduction for CB2 receptor
Zhang, Y., Xie, Z., Wang, L., Schreiter, B. R., Lazo, J. S., Gertsch, J., & Xie, X. (2011) · International Immunopharmacology · doi:10.1016/j.intimp.2011.04.013 · Cited by 27
Expression of functionally active cannabinoid receptor CB1 in the human prostate gland
Ruiz‐Llorente, L., Sánchez‐Alonso, M. G., Carmena, M. J., Prieto, J. C., Sánchez‐Chapado, M., Izquierdo, A., & Díaz‐Laviada, I. (2002) · The Prostate · doi:10.1002/pros.10165 · Cited by 27
A cannabinoid receptor 1 mutation proximal to the DRY motif results in constitutive activity and reveals intramolecular interactions involved in receptor activation
D’Antona, A. M., Ahn, K. H., Wang, L., Mierke, D. F., Lucas-Lenard, J. M., & Kendall, D. A. (2006) · Brain Research · doi:10.1016/j.brainres.2006.05.042 · Cited by 26
Analysis of natural product regulation of cannabinoid receptors in the treatment of human disease
Badal, S. A. M., Smith, K. N., & Rajnarayanan, R. V. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.06.003 · Cited by 27
Effects of Δ9-THC on VIP-induced prolactin secretion in anterior pituitary cultures: evidence for the presence of functional cannabinoid CB1 receptors in pituitary cells
de Fonseca, F. R., Wenger, T., Navarro, M. A., & Murphy, L. L. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01809-0 · Cited by 26
Acute and chronic activation of the μ-opioid receptor with the endogenous ligand endomorphin differentially regulates adenylyl cyclase isozymes
Nevo, I., Avidor‐Reiss, T., Levy, R., Bayewitch, M. L., & Vogel, Z. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(99)00155-0 · Cited by 25
Brain endocannabinoid signaling exhibits remarkable complexity
Gorzkiewicz, A., & Szemraj, J. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.06.012 · Cited by 26
Δ9‐Tetrahydrocannabinol increases nerve growth factor production by prostate PC‐3 cells
Velasco, L., Ruiz, L., Sánchez‐Alonso, M. G., & Díaz‐Laviada, I. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.01884.x · Cited by 23
Cannabinoids and the Cannabinoid Receptors: An Overview
Lu, D., & Potter, D. E. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-800756-3.00068-5 · Cited by 23
Endocannabinoid system contributions to sex-specific adolescent neurodevelopment
Simone, J. J., Green, M. R., & McCormick, C. M. (2021) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2021.110438 · Cited by 25
Reciprocal influences of CB1cannabinoid receptor agonists on ERK and JNK signalling in N1E‐115 cells
Bosier, B., Lambert, D. M., & Hermans, E. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.10.022 · Cited by 21
Adenylyl cyclase type II activity is regulated by two different mechanisms: Implications for acute and chronic opioid exposure
Schallmach, E., Steiner, D., & Vogel, Z. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.01.004 · Cited by 21
Anandamide in primary sensory neurons: too much of a good thing?
Valente, J. D. S., Varga, A., Ananthan, K., Khajuria, A., & Nagy, I. (2014) · European Journal of Neuroscience · doi:10.1111/ejn.12467 · Cited by 20
Platelet Adenylyl Cyclase Activity as a State or Trait Marker in Alcohol Dependence: Results of the WHO/ISBRA Study on State and Trait Markers of Alcohol Use and Dependence
Hoffman, P. L., Glanz, J. M., & Tabakoff, B. (2002) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2002.tb02642.x · Cited by 20
Inhibition and Superactivation of the Calcium-Stimulated Isoforms of Adenylyl Cyclase: Role of Gβγ Dimers
Steiner, D., Avidor‐Reiss, T., Schallmach, E., Saya, D., & Vogel, Z. (2005) · Journal of Molecular Neuroscience · doi:10.1385/jmn:27:2:195 · Cited by 18
Khat (Catha edulis F.) and cannabinoids: Parallel and contrasting behavioral effects in preclinical and clinical studies
Kibret, B. G. (2015) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2015.09.019 · Cited by 18
Cell Type-Specific Tandem Affinity Purification of the Mouse Hippocampal CB1 Receptor-Associated Proteome
Mattheus, T., Kukla, K., Zimmermann, T., Tenzer, S., & Lutz, B. (2016) · Journal of Proteome Research · doi:10.1021/acs.jproteome.6b00339 · Cited by 16
N-Oleoylglycine-Induced Hyperphagia Is Associated with the Activation of Agouti-Related Protein (AgRP) Neuron by Cannabinoid Receptor Type 1 (CB1R)
Wu, J., Zhu, C., Yang, L., Wang, Z., Wang, L., Wang, S., Gao, P., Zhang, Y., Jiang, Q., Zhu, X., et al. (2017) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.6b05281 · Cited by 17
Alternative Interacting Sites and Novel Receptors for Cannabinoid Ligands
Köfalvi, A. (2007) · Springer eBooks · doi:10.1007/978-0-387-74349-3_9 · Cited by 17
Cannabinoid receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database
Abood, M. E., Alexander, S. P. H., Barth, F., Bonner, T. I., Bradshaw, H. B., Cabral, G. A., Casellas, P., Cravatt, B. F., Devane, W. A., Marzo, V. D., et al. (2019) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f13/2019.4 · Cited by 15
Role of Cannabinoid CB2 Receptor in Alcohol Use Disorders: From Animal to Human Studies
García‐Gutiérrez, M. S., Navarrete, F., Gasparyan, A., Navarro, D., Morcuende, Á., Femenía, T., & Manzanares, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23115908 · Cited by 14
Time-dependent induction of CREB phosphorylation in the hippocampus by the endogenous cannabinoid
Isokawa, M. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.04.003 · Cited by 14
No more pain upon G q‐protein‐coupled receptor activation: role of endocannabinoids
Hu, S. S., Ho, Y., & Chiou, L. (2014) · European Journal of Neuroscience · doi:10.1111/ejn.12475 · Cited by 16
Retracted
Cannabinoids: Role in Neurological Diseases and Psychiatric Disorders
Kumar, U. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms26010152 · Cited by 15
Parkinson’s disease related alterations in cannabinoid transmission
Soti, M., Ranjbar, H., Kohlmeier, K. A., & Shabani, M. (2021) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2021.11.009 · Cited by 11
Endogenous and synthetic cannabinoids induce the downregulation of cannabinoid CB1 receptor in retina
Papadogkonaki, S., Theodorakis, Κ., & Thermos, K. (2019) · Experimental Eye Research · doi:10.1016/j.exer.2019.107694 · Cited by 11
A review of the direct targets of the cannabinoids cannabidiol, Δ9-tetrahydrocannabinol, N-arachidonoylethanolamine and 2-arachidonoylglycerol
Wright, N. J. D. (2024) · AIMS neuroscience · doi:10.3934/neuroscience.2024009 · Cited by 11
Regulation of adenylate cyclase type VIII splice variants by acute and chronic Gi/o-coupled receptor activation
Steiner, D., Avidor‐Reiss, T., Schallmach, E., Butovsky, E., Lev, N., & Vogel, Z. (2005) · Biochemical Journal · doi:10.1042/bj20041670 · Cited by 10
Cannabis and the immune response: A comprehensive review of therapeutic potential and concerns
Barakat, M. M., Thiab, S. H., Alzaghari, L. F., Abdulrazzaq, S. B., Hasen, E., Abuarab, S. F., Nasereddin, L., Omar, A., Barakat, Y., Chellappan, D. K., et al. (2025) · Phytomedicine Plus · doi:10.1016/j.phyplu.2025.100876 · Cited by 10
Concomitant activation of adenylyl cyclase suppresses the opposite influences of CB1 cannabinoid receptor agonists on tyrosine hydroxylase expression
Bosier, B., Hermans, E., & Lambert, D. M. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.10.010 · Cited by 9

Authors: Rhee, M., Bayewitch, M., Avidor‐Reiss, T., Levy, R., & Vogel, Z.
Affiliations: Weizmann Institute of Science (IL)
Corresponding author: Vogel, Zvi
ORCID: Rhee, Man‐Hee
Avidor‐Reiss, Tomer
Levy, Rivka
Venue: Journal of Neurochemistry
Publisher: Wiley
Published: 1998-10
Volume: 71
Issue: 4
Pages: 1525-1534
ISSN: 0022-3042 (ISSN-L)
1471-4159
DOI: 10.1046/j.1471-4159.1998.71041525.x
OpenAlex: W2035086154
Cited by: 159
References: 56
Citations by year: 2026: 2 · 2025: 2 · 2024: 3 · 2023: 5 · 2022: 6 · 2021: 6 · 2020: 8 · 2019: 7 · 2018: 5 · 2017: 6 · 2016: 7 · 2015: 3 · 2014: 10 · 2013: 4 · 2012: 1
FWCI: 3.42
Type: journal article
Language: en
Open access: closed
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor, 1504 d)
Locations: Journal of Neurochemistry (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (5r01da006265-09)
National Institute on Drug Abuse (DA 06265)
Topics: Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords: cannabinoid receptors, CB1 receptor, CB2 receptor, G protein-coupled receptors, G protein signaling, adenylate cyclase inhibition, forskolin, beta gamma subunits, thyroid-stimulating hormone receptor, cotransfection
MeSH terms: Adenylyl Cyclase Inhibitors, Adenylyl Cyclases, Animals, Cannabinoids, Enzyme Activation, Humans, Isoenzymes, Morpholines, Naphthalenes, Receptors, Drug, Dronabinol, Transfection, COS Cells, Receptors, Cannabinoid, Receptor, Cannabinoid, CB2, Benzoxazines, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Cannabinoid Receptor Activation Differentially Regulates the Various Adenylyl Cyclase Isozymes

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks